Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
27,784,592
-
Share change
-
+207,449
-
Total reported value
-
$3,965,954,154
-
Put/Call ratio
-
143%
-
Price per share
-
$142.77
-
Number of holders
-
194
-
Value change
-
+$70,956,802
-
Number of buys
-
101
-
Number of sells
-
91
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q4 2020
As of 31 Dec 2020,
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) was held by
194 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,784,592 shares.
The largest 10 holders included
CAS Investment Partners, LLC, BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, KPS Global Asset Management UK Ltd, Alua Capital Management LP, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, and LORD, ABBETT & CO. LLC.
This page lists
194
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.